Trials
A prospective multicentre double-blind randomized controlled trial evaluating clinical, cognitive and neural effects of potentiation of electroconvulsive therapy by repetitive transcranial magnetic stimulation in patients with treatment-resistant depression (STIMAGNECT 2).
Léa Clabeau, Virginie Moulier, Bastien Kaczmarek, Marine Dalmont, Jean-Marie Batail, Noomane Bouaziz, Jérôme Brunelin, Benjamin Calvet, Christophe Daudet, Sonia Dollfus, Philippe Domenech, Dominique Drapier, Filipe Galvao, Bénédicte Gohier, Ghina Harika-Germaneau
Published: 202610.1186/s13063-025-09406-4
Abstract
BACKGROUND: Major depressive disorder is a leading cause of disability worldwide, with treatment-resistant depression (TRD) affecting approximately one-third of patients and leading to increased morbidity and healthcare costs. Electroconvulsive thera…
Preview only. Read the full abstract at the source